These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37453475)

  • 21. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
    Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
    Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
    Vogel R
    ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Watching the Detectives" report of the general assembly of the EU project DETECTIVE Brussels, 24-25 November 2015.
    Fernando RN; Chaudhari U; Escher SE; Hengstler JG; Hescheler J; Jennings P; Keun HC; Kleinjans JCS; Kolde R; Kollipara L; Kopp-Schneider A; Limonciel A; Nemade H; Nguemo F; Peterson H; Prieto P; Rodrigues RM; Sachinidis A; Schäfer C; Sickmann A; Spitkovsky D; Stöber R; van Breda SGJ; van de Water B; Vivier M; Zahedi RP; Vinken M; Rogiers V
    Arch Toxicol; 2016 Jun; 90(6):1529-1539. PubMed ID: 27129694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-animal approaches for toxicokinetics in risk evaluations of food chemicals.
    Punt A; Peijnenburg AACM; Hoogenboom RLAP; Bouwmeester H
    ALTEX; 2017; 34(4):501-514. PubMed ID: 28403478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative in vitro models used in the main safety tests of cosmetic products and new challenges.
    Filaire E; Nachat-Kappes R; Laporte C; Harmand MF; Simon M; Poinsot C
    Int J Cosmet Sci; 2022 Dec; 44(6):604-613. PubMed ID: 35842748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety evaluations under the proposed US Safe Cosmetics and Personal Care Products Act of 2013: animal use and cost estimates.
    Knight J; Rovida C
    ALTEX; 2014; 31(2):177-208. PubMed ID: 24468774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
    McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond dermal exposure: The respiratory tract as a target organ in hazard assessments of cosmetic ingredients.
    Thá EL; Canavez ADPM; Schuck DC; Gagosian VSC; Lorencini M; Leme DM
    Regul Toxicol Pharmacol; 2021 Aug; 124():104976. PubMed ID: 34139277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of alternative methods to the use of animals in safety evaluation of cosmetics.
    Nabarretti BH; Rigon RB; Burga-Sánchez J; Leonardi GR
    Einstein (Sao Paulo); 2022; 20():eRB5578. PubMed ID: 35137796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critique of the EC's expert (draft) reports on the status of alternatives for cosmetics testing to meet the 2013 deadline.
    Taylor K; Casalegno C; Stengel W
    ALTEX; 2011; 28(2):131-48. PubMed ID: 21625829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro testing strategy for assessing the skin sensitizing potential of "difficult to test" cosmetic ingredients.
    Bergal M; Puginier M; Gerbeix C; Groux H; Roso A; Cottrez F; Milius A
    Toxicol In Vitro; 2020 Jun; 65():104781. PubMed ID: 32001296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards an integrated in vitro strategy for repeated dose toxicity testing.
    Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
    Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
    [No Abstract]   [Full Text] [Related]  

  • 35. Working in partnership to advance the 3Rs in toxicity testing.
    Holmes AM; Creton S; Chapman K
    Toxicology; 2010 Jan; 267(1-3):14-9. PubMed ID: 19903508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Silico Models for Skin Sensitization and Irritation.
    Selvestrel G; Robino F; Russo MZ
    Methods Mol Biol; 2022; 2425():291-354. PubMed ID: 35188638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An International Perspective on the Tools and Concepts for Effluent Toxicity Assessments in the Context of Animal Alternatives: Reduction in Vertebrate Use.
    Norberg-King TJ; Embry MR; Belanger SE; Braunbeck T; Butler JD; Dorn PB; Farr B; Guiney PD; Hughes SA; Jeffries M; Journel R; Lèonard M; McMaster M; Oris JT; Ryder K; Segner H; Senac T; Van Der Kraak G; Whale G; Wilson P
    Environ Toxicol Chem; 2018 Nov; 37(11):2745-2757. PubMed ID: 30359486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report from the EPAA workshop: in vitro ADME in safety testing used by EPAA industry sectors.
    Schroeder K; Bremm KD; Alépée N; Bessems JG; Blaauboer B; Boehn SN; Burek C; Coecke S; Gombau L; Hewitt NJ; Heylings J; Huwyler J; Jaeger M; Jagelavicius M; Jarrett N; Ketelslegers H; Kocina I; Koester J; Kreysa J; Note R; Poth A; Radtke M; Rogiers V; Scheel J; Schulz T; Steinkellner H; Toeroek M; Whelan M; Winkler P; Diembeck W
    Toxicol In Vitro; 2011 Apr; 25(3):589-604. PubMed ID: 21167275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.
    Almeida A; Sarmento B; Rodrigues F
    Int J Pharm; 2017 Mar; 519(1-2):178-185. PubMed ID: 28104405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The way forward in reproductive/developmental toxicity testing.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.